ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 206 filers reported holding ROIVANT SCIENCES LTD in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 1.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 66,719,779 | $705,228,064 | 66.32% |
| Patient Square Capital LP | 12,228,465 | $129,254,875 | 59.99% |
| Atalaya Capital Management LP | 1,714,843 | $18,125,891 | 40.31% |
| Two Seas Capital LP | 10,318,764 | $109,069,335 | 17.73% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $51,081,026 | 15.77% |
| Whitefort Capital Management, LP | 2,391,000 | $25,272,870 | 15.58% |
| STEMPOINT CAPITAL LP | 2,712,741 | $28,673,672 | 8.43% |
| Tejara Capital Ltd | 2,183,943 | $23,084,278 | 8.39% |
| Tyro Capital Management LLC | 1,744,327 | $18,437,536 | 8.36% |
| ADAR1 Capital Management, LLC | 4,150,009 | $43,865,595 | 8.28% |